TP53 and triple-negative breast carcinoma: This meta-analysis highlights the elevated expression of drug-resistant proteins (GST-π, PGP, P53, and Ki-67) in triple-negative breast cancer (TNBC), suggesting a strong link to chemotherapy resistance and poor clinical outcomes.